Heterogeneity of Myc expression in breast cancer exposes pharmacological vulnerabilities revealed through executable mechanistic modeling.

Proc Natl Acad Sci U S A · 2019 · PMC6825310 · PMID 31611367

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

a strong trendP = 0.054so close (0.05 < p ≤ 0.1)

However, like Myc high -only tumors, and quite unlike Myc low -only tumors, Myc high /Myc low chimeric tumors were invasive, angiogenic, and predominantly normoxic, exhibiting little necrosis and displaying a strong trend toward increased cellularity ( P = 0.054) ( Fig. 2 C – F and SI Appendix , Fig.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.